GlassScriptPrepare for your visit
Darlene Kim
Cardiovascular Disease · Denver, CO · NPI 1518161892
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$4,323.03
in general payments reported to CMS, 2019-2025 · $825 in 2025
The $825 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Who reported paying
General payments only, top 6 by amount.
- Actelion Pharmaceuticals US, INC. $1,726.80
- United Therapeutics Corporation $1,028.69
- Boston Scientific Corporation $540.79
- Zoll Services LLC (A/K/A Zoll Lifecor Corp) $215.23
- Inari Medical, INC. $215.17
- Bayer Healthcare Pharmaceuticals INC. $209.65
Drugs and devices associated with these payments
Watchman Access System Tyvaso Lifevest Kerendia Uptravi Watchman Flx Lodoco Opsumit Perclose Proglide Dexcom G6 Transmitter Repatha
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Darlene Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/295023/darlene-kim